+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Herantis Pharma plc - logo

Herantis Pharma is a specialty pharmaceutical company based in Helsinki, Finland. It specializes in drugs for the treatment of dry eye, Parkinson's diseases, amyotrophic lateral sclerosis (ALS) and secondary lymphedema. They are developing selected drug candidates through late preclinical and early clinical stages. Herantis products in pipeline include Cis-UCA eye drops, CDNF for the treatment of Parkinson's Diseases ALS; and Lymfactin, which is in clinical trials for treating breast cancer.

Lymphoedema - Pipeline Insight, 2021 - Product Thumbnail Image

Lymphoedema - Pipeline Insight, 2021

  • Drug Pipelines
  • January 2021
  • 60 pages
Amblyopia Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Amblyopia Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • October 2018
  • 47 pages
Herantis Pharma Oyj - Product Thumbnail Image

Herantis Pharma Oyj

  • Company Profile
  • December 2018
  • 71 Pages
  • 11 Results (Page 1 of 1)
Loading Indicator